RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cosmos Pharmaceutical - Stock

Cosmos Pharmaceutical Net Income 2024

Cosmos Pharmaceutical Net Income

25.24 B JPY

Ticker

3349.T

ISIN

JP3298400007

In 2024, Cosmos Pharmaceutical's profit amounted to 25.24 B JPY, a 6.07% increase from the 23.8 B JPY profit recorded in the previous year.

The Cosmos Pharmaceutical Net Income history

YEARNET INCOME (undefined JPY)
2026e29.3
2025e26.91
2024e25.24
202323.8
202223.16
202127.16
202021.44
201919.19
201817.63
201718.22
201612.44
201511.69
201410.6
20139.4
20127.74
20115.74
20104.71
20092.84
20082.17
20072.3
20061.94
20051.24
20040.93

Cosmos Pharmaceutical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cosmos Pharmaceutical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cosmos Pharmaceutical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cosmos Pharmaceutical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cosmos Pharmaceutical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cosmos Pharmaceutical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cosmos Pharmaceutical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cosmos Pharmaceutical’s growth potential.

Cosmos Pharmaceutical Revenue, EBIT and net profit per share

DateCosmos Pharmaceutical RevenueCosmos Pharmaceutical EBITCosmos Pharmaceutical Net Income
2026e1.15 T undefined0 undefined29.3 B undefined
2025e1.06 T undefined38.24 B undefined26.91 B undefined
2024e972.95 B undefined35.41 B undefined25.24 B undefined
2023827.7 B undefined30.13 B undefined23.8 B undefined
2022755.41 B undefined29.8 B undefined23.16 B undefined
2021726.42 B undefined33.15 B undefined27.16 B undefined
2020684.4 B undefined29.09 B undefined21.44 B undefined
2019611.14 B undefined24.78 B undefined19.19 B undefined
2018558 B undefined22.75 B undefined17.63 B undefined
2017502.73 B undefined22.24 B undefined18.22 B undefined
2016447.27 B undefined18.65 B undefined12.44 B undefined
2015408.47 B undefined17.08 B undefined11.69 B undefined
2014371.83 B undefined16.71 B undefined10.6 B undefined
2013329.31 B undefined15.53 B undefined9.4 B undefined
2012279.02 B undefined13.33 B undefined7.74 B undefined
2011237.17 B undefined10.04 B undefined5.74 B undefined
2010205.39 B undefined7.74 B undefined4.71 B undefined
2009177.76 B undefined4.58 B undefined2.84 B undefined
2008148.24 B undefined3.51 B undefined2.17 B undefined
2007125.85 B undefined3.77 B undefined2.3 B undefined
2006105.05 B undefined3.41 B undefined1.94 B undefined
200578.65 B undefined2.25 B undefined1.24 B undefined
200459.41 B undefined1.67 B undefined929 M undefined

Cosmos Pharmaceutical stock margins

The Cosmos Pharmaceutical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cosmos Pharmaceutical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cosmos Pharmaceutical.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cosmos Pharmaceutical's sales revenue. A higher gross margin percentage indicates that the Cosmos Pharmaceutical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cosmos Pharmaceutical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cosmos Pharmaceutical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cosmos Pharmaceutical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cosmos Pharmaceutical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cosmos Pharmaceutical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cosmos Pharmaceutical Margin History

Cosmos Pharmaceutical Gross marginCosmos Pharmaceutical Profit marginCosmos Pharmaceutical EBIT marginCosmos Pharmaceutical Profit margin
2026e20.38 %0 %2.56 %
2025e20.38 %3.61 %2.54 %
2024e20.38 %3.64 %2.59 %
202320.38 %3.64 %2.88 %
202220.05 %3.94 %3.07 %
202119.98 %4.56 %3.74 %
202019.72 %4.25 %3.13 %
201919.93 %4.05 %3.14 %
201819.77 %4.08 %3.16 %
201719.9 %4.42 %3.62 %
201619.42 %4.17 %2.78 %
201519.11 %4.18 %2.86 %
201418.98 %4.49 %2.85 %
201318.76 %4.72 %2.85 %
201218.99 %4.78 %2.77 %
201119.19 %4.23 %2.42 %
201019.51 %3.77 %2.29 %
200919.77 %2.57 %1.6 %
200822.06 %2.37 %1.47 %
200722.53 %2.99 %1.83 %
200622.17 %3.25 %1.85 %
200522.52 %2.87 %1.58 %
200421.88 %2.81 %1.56 %

Cosmos Pharmaceutical Aktienanalyse

What does Cosmos Pharmaceutical do?

Cosmos Pharmaceuticals Corp is a Taiwanese company that was founded in 1984. The company specializes in the manufacturing and selling of pharmaceutical and health products, focusing on the needs of patients and healthcare providers. Cosmos Pharmaceuticals Corp has developed a strong business model over the years based on high-quality products, efficient production, and a strong distribution network. The company aims to offer a wide range of products and services to meet customers' needs. It is divided into three main business segments: manufacturing and marketing of drugs, manufacturing and selling of dietary supplements, and sales of medical devices. In the pharmaceutical manufacturing sector, Cosmos Pharmaceuticals Corp offers various drugs, including generics and innovative products that can be used for various conditions such as hypertension, diabetes, and obesity. The company also operates a specialized research center where new active ingredients and therapies are developed. In the dietary supplement sector, Cosmos Pharmaceuticals Corp is known for its products supporting cardiovascular health, immune function, and supplements for the maintenance of hair and skin health. The medical devices division of Cosmos Pharmaceuticals Corp offers a wide range of medical and diagnostic devices, including blood glucose meters, blood pressure monitors, and other devices used by patients and healthcare providers in hospitals and clinics. Furthermore, Cosmos Pharmaceuticals Corp has been committed to quality and customer satisfaction from the beginning. The company has implemented strict quality control standards and a comprehensive quality control system to ensure that all products and services meet the highest standards. The company also has an extensive customer service department that ensures prompt and effective handling of customer inquiries and complaints. Due to its focus on quality products, efficient production, and a strong distribution network, Cosmos Pharmaceuticals Corp has built an excellent reputation over the years. The company has managed to strengthen its presence in Asia and Europe and expand its product range. Cosmos Pharmaceuticals Corp has also established itself as a leading provider of generic and innovative products in Southeast Asia. In summary, Cosmos Pharmaceuticals Corp is a successful and forward-thinking company that strives to meet the needs of its customers and offers a wide range of products and services. With its strong position in the pharmaceutical, dietary supplement, and medical device industries, Cosmos Pharmaceuticals Corp is a company that will continue to grow in the future. Cosmos Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Cosmos Pharmaceutical's Profit Margins

The profit margins of Cosmos Pharmaceutical represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Cosmos Pharmaceutical's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Cosmos Pharmaceutical's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Cosmos Pharmaceutical's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Cosmos Pharmaceutical’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Cosmos Pharmaceutical Stock

How much profit has Cosmos Pharmaceutical made this year?

Cosmos Pharmaceutical has made 25.24 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 6.07% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Cosmos Pharmaceutical publish its earnings?

Cosmos Pharmaceutical publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Cosmos Pharmaceutical?

The profits of Cosmos Pharmaceutical are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Cosmos Pharmaceutical?

You can learn more about the earnings of Cosmos Pharmaceutical by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Cosmos Pharmaceutical pay?

Over the past 12 months, Cosmos Pharmaceutical paid a dividend of 117.5 JPY . This corresponds to a dividend yield of about 0.91 %. For the coming 12 months, Cosmos Pharmaceutical is expected to pay a dividend of 129.92 JPY.

What is the dividend yield of Cosmos Pharmaceutical?

The current dividend yield of Cosmos Pharmaceutical is 0.91 %.

When does Cosmos Pharmaceutical pay dividends?

Cosmos Pharmaceutical pays a quarterly dividend. This is distributed in the months of December, June, December, June.

How secure is the dividend of Cosmos Pharmaceutical?

Cosmos Pharmaceutical paid dividends every year for the past 22 years.

What is the dividend of Cosmos Pharmaceutical?

For the upcoming 12 months, dividends amounting to 129.92 JPY are expected. This corresponds to a dividend yield of 1 %.

In which sector is Cosmos Pharmaceutical located?

Cosmos Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Cosmos Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cosmos Pharmaceutical from 8/1/2024 amounting to 60 JPY, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Cosmos Pharmaceutical pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Cosmos Pharmaceutical in the year 2023?

In the year 2023, Cosmos Pharmaceutical distributed 82.5 JPY as dividends.

In which currency does Cosmos Pharmaceutical pay out the dividend?

The dividends of Cosmos Pharmaceutical are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cosmos Pharmaceutical

Our stock analysis for Cosmos Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmos Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.